Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Nucleotide analog; RT inhibitor.
Mixture of quaternary ammonium salts, cationic ...
Long chain acylcarnitine involved in fatty acid...
Pentacyclic triterpene found in various plant s...
Tyrosine kinase inhibitor.
AMPK activator.
Coccidiostat.
Anthraquinone found in various plant sources.
Camptothecin derivative; topoisomerase I inhibi...
Anthracycline, DNA intercalator; topoisomerase ...
VEGFR, PDGFR, c-Kit, RET inhibitor.
Vitamin D, calcitriol prodrug; VDR agonist.
Proteasome inhibitor.
Focal adhesion kinase (FAK) inhibitor.
Pt-based DNA cross-linker.
Carbonic anhydrase inhibitor.
Synthetic steroid hormone; AR agonist, ER and P...
FIASMA, histamine H1 inverse agonist, 5-HT2A, D...
Valsartan impurity
Synthetic catechol; ER agonist, microtubule pol...